Rating Change
B of A Securities reiterated its Buy rating on Sana Biotechnology, Inc. (NASDAQ:SANA) on August 14, 2026.
reiterateNASDAQ:SANA
B of A Securities Reiterates Buy Rating on Sana Biotechnology, Inc. (SANA)
B of A Securities reiterated its Buy rating on Sana Biotechnology, Inc. (NASDAQ:SANA) on August 14, 2026.
At publication ·
What changed
Sana Biotechnology, Inc. (NASDAQ:SANA) · reiterate
- Firm
- B of A Securities
- Rating
- Buy to Buy
- Price at event
- $3.55
- Market capitalization
- $1.3B
At a glance
Key takeaways
- B of A Securities reiterated its Buy rating on Sana Biotechnology (SANA) on August 14, 2026, with the stock trading at $3.55 and a market capitalization of $1.3 billion.
Market Context
Sana Biotechnology, Inc. operates in the Healthcare sector. The stock currently trades at $3.55 with a market capitalization of $1.3B.
Analyst coverage from B of A Securities provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Sana Biotechnology, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Sana Biotechnology, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 14, 2026 | B of A Securities | Buy | N/A |
| Apr 14, 2026 | Wedbush | Outperform | N/A |
| Mar 04, 2026 | HC Wainwright & Co. | Buy | N/A |
| Jan 06, 2026 | B of A Securities | Buy | N/A |
| Nov 07, 2025 | Wedbush | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View SANA Stock Page
Frequently Asked Questions
What does the Buy rating mean for SANA?
A rating of Buy from B of A Securities reflects the analyst's outlook on Sana Biotechnology, Inc. (NASDAQ:SANA). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the SANA forecast page.